Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and di
![Pharmaceuticals | Free Full-Text | Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Pharmaceuticals | Free Full-Text | Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00095/article_deploy/html/images/pharmaceuticals-15-00095-g001.png?1642647326)
Pharmaceuticals | Free Full-Text | Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic
![Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | Nature Communications Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25066-9/MediaObjects/41467_2021_25066_Fig1_HTML.png)
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | Nature Communications
![Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin | Scientific Reports Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65689-4/MediaObjects/41598_2020_65689_Fig1_HTML.png)
Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin | Scientific Reports
![IJMS | Free Full-Text | Biological Mechanisms of Paeonoside in the Differentiation of Pre-Osteoblasts and the Formation of Mineralized Nodules IJMS | Free Full-Text | Biological Mechanisms of Paeonoside in the Differentiation of Pre-Osteoblasts and the Formation of Mineralized Nodules](https://www.mdpi.com/ijms/ijms-22-06899/article_deploy/html/images/ijms-22-06899-g001.png)
IJMS | Free Full-Text | Biological Mechanisms of Paeonoside in the Differentiation of Pre-Osteoblasts and the Formation of Mineralized Nodules
![JCM | Free Full-Text | Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan JCM | Free Full-Text | Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan](https://www.mdpi.com/jcm/jcm-10-05732/article_deploy/html/images/jcm-10-05732-g001.png)
JCM | Free Full-Text | Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan
![IJMS | Free Full-Text | IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis IJMS | Free Full-Text | IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis](https://www.mdpi.com/ijms/ijms-23-00555/article_deploy/html/images/ijms-23-00555-g001-550.jpg)
IJMS | Free Full-Text | IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis
![A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice | Scientific Reports A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-18671-1/MediaObjects/41598_2022_18671_Fig1_HTML.png)
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice | Scientific Reports
![Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA) | Scientific Reports Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA) | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-18790-9/MediaObjects/41598_2022_18790_Fig1_HTML.png)
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA) | Scientific Reports
![IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis - ScienceDirect IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0091674919306827-fx1.jpg)
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis - ScienceDirect
![Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness](https://www.mdpi.com/life/life-12-02050/article_deploy/html/images/life-12-02050-g001-550.jpg)